NCT00094133

Brief Summary

RATIONALE: Hypnosis may be effective in decreasing hot flashes in breast cancer survivors. PURPOSE: This randomized clinical trial is studying how well hypnosis works in treating hot flashes in breast cancer survivors.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 14, 2004

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 15, 2004

Completed
1.5 years until next milestone

Study Start

First participant enrolled

April 1, 2006

Completed
Last Updated

September 20, 2013

Status Verified

September 1, 2007

First QC Date

October 14, 2004

Last Update Submit

September 19, 2013

Conditions

Keywords

cancer survivorstage IA breast cancerstage IB breast cancerstage II breast cancerstage IIIA breast cancerstage IIIB breast cancerstage IIIC breast cancerstage IV breast cancerbreast cancer in situinflammatory breast cancerhot flashes

Outcome Measures

Primary Outcomes (1)

  • Hot flash control by Hot Flash Daily Diary in week 6

Interventions

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
DISEASE CHARACTERISTICS: * History of primary breast cancer * No evidence of detectable disease * At least 14 hot flashes per week for ≥ 1 month by self-reporting * Hormone receptor status not specified PATIENT CHARACTERISTICS: * Female * Life expectancy \> 6 months * Menopausal status not specified * Outpatient status * No medical or psychiatric condition that would preclude study participation PRIOR CONCURRENT THERAPY: * Concurrent antihormonal agents for breast cancer (e.g., tamoxifen or raloxifene) allowed provided the patient has been on them for ≥ 1 month * No other concurrent hormonal therapy * No other putative therapies for hot flashes ≥ 1 month prior to study entry * Concurrent vitamin E allowed * No other concurrent treatment for hot flashes * No concurrent cytotoxic chemotherapy * Not concurrently using hypnosis for any reason

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Scott and White Cancer Institute

Temple, Texas, 76508, United States

RECRUITING

Related Publications (1)

  • Elkins G, Marcus J, Stearns V, Perfect M, Rajab MH, Ruud C, Palamara L, Keith T. Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors. J Clin Oncol. 2008 Nov 1;26(31):5022-6. doi: 10.1200/JCO.2008.16.6389. Epub 2008 Sep 22.

MeSH Terms

Conditions

Breast NeoplasmsHot FlashesBreast Carcinoma In SituInflammatory Breast Neoplasms

Interventions

Hypnosis

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCarcinoma in SituCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Gary Elkins, PhD

    Scott and White Hospital & Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Purpose
SUPPORTIVE CARE
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 14, 2004

First Posted

October 15, 2004

Study Start

April 1, 2006

Last Updated

September 20, 2013

Record last verified: 2007-09

Locations